Restless Leg Syndrome in ADHD children : Levetiracetam as a reasonable therapeutic option
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-06-06
著者
-
Spina Edoardo
Section Of Pharmacology Department Of Clinical And Experimental Medicine And Pharmacology University
-
Cedro Clemente
Sleep Medicine Centre Department Of Neurosciences Psychiatric And Anaesthesiological Sciences Univer
-
GAGLIANO Antonella
Division of Child Neurology and Psychiatry, Department of Pediatrics, University of Messina
-
ARICO Irene
Sleep Medicine Centre, Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, Uni
-
CALARESE Tiziana
Division of Child Neurology and Psychiatry, Department of Pediatrics, University of Messina
-
CONDURSO Rosaria
Sleep Medicine Centre, Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, Uni
-
GERMANO Eva
Division of Child Neurology and Psychiatry, Department of Pediatrics, University of Messina
-
SILVESTRI Rosalia
Sleep Medicine Centre, Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, Uni
-
Arico Irene
Sleep Medicine Centre Department Of Neurosciences Psychiatric And Anaesthesiological Sciences Univer
-
Germano Eva
Division Of Child Neurology And Psychiatry Department Of Pediatrics University Of Messina
-
Condurso Rosaria
Sleep Medicine Centre Department Of Neurosciences Psychiatric And Anaesthesiological Sciences Univer
-
Calarese Tiziana
Division Of Child Neurology And Psychiatry Department Of Pediatrics University Of Messina
-
Silvestri Rosalia
Sleep Medicine Centre Department Of Neurosciences Psychiatric And Anaesthesiological Sciences Univer
-
Gagliano Antonella
Division Of Child Neurology And Psychiatry Department Of Pediatrics University Of Messina
-
Spina Edoardo
Section Of Pharmacology Department Of Clinical And Experimental Medicine And Pharmacology University
関連論文
- Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography
- Restless Leg Syndrome in ADHD children : Levetiracetam as a reasonable therapeutic option
- Plasma Concentrations of Risperidone and Olanzapine during Coadministration with Oxcarbazepine